FRESENIUS KABI PHARMA PORTUGAL, LDA. secures contract for Call For Proposals Under Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 437 - Anti-Allergy Medicine Vitamins And Minerals And Medicines

Portugal, May 25 -- Portugal based FRESENIUS KABI PHARMA PORTUGAL, LDA. has secured contract from Unidade Local De Saude Do Alto Minho, Epe (Ulsam) for Call For Proposals Under Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 437 - Anti-Allergy Medicine Vitamins And Minerals And Medicines . The value of the contract is worth 151920 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....